Fagron N.V.
Fagron N.V. (ARSUF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARSUF · as of Jun 8, 2026
Key Statistics
Explore Fagron N.V. Data
arsuf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
arsuf competitorsARSUF
CASBF
CURLF
DMPHF
EBOSY
GTBIFStock Performance
Full HistoryAbout Fagron N.V.
Fagron N.V. Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations fo…
what is fagron n.v. · arsuf stock overview · fagron n.v. company profile · who is fagron n.v. ceo · arsuf OTC · fagron n.v. headquarters · fagron n.v. business segments
About Stock Overview & Key Data
Fagron N.V. (ARSUF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Feb 21, 2017. As of the latest trading session, ARSUF stock price is $26.53, with a market capitalization of $1.9B. The stock has returned +32.45% over the past 12 months and +12.89% year-to-date.
In fiscal year 2025, Fagron N.V. reported revenue of $951.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fagron N.V. (ARSUF) stock price is $26.53. The stock is traded on OTC under the ticker symbol ARSUF. The 52-week range is $20.03 – $27.00.